<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="46525">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02500563</url>
  </required_header>
  <id_info>
    <org_study_id>6032</org_study_id>
    <nct_id>NCT02500563</nct_id>
  </id_info>
  <brief_title>Exploratory/Proof of Principle Microbiota Study</brief_title>
  <official_title>Exploratory/Proof of Principle Microbiota Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mead Johnson Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Midwest Children's Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mead Johnson Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial will evaluate the stool of infants fed one of two infant formulas, which
      contain different types of proteins, or breast milk to determine if different proteins have
      an effect on the type of bacteria that enters and lives in an infant's intestine early in
      life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This clinical trial will evaluate the stool of infants fed one of two infant formulas, which
      contain different types of proteins, or breast milk to determine if different proteins have
      an effect on the type of bacteria that enters and lives in an infant's intestine early in
      life.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double Blind (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fecal microbiota measured at each visit</measure>
    <time_frame>8 weeks</time_frame>
    <description>Sequencing and composition of samples</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body weight measured at each visit</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measurement collected with a calibrated infant scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body length measured at each visit</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measurement collected with a standardized length board</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Head circumference measured at each visit</measure>
    <time_frame>8 weeks</time_frame>
    <description>Measurement collected with a standardized measuring tape</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parental recall of formula intake at each visit</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stool collection at each visit</measure>
    <time_frame>8 weeks</time_frame>
    <description>Composite measure of pH and short chain fatty acids</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serious adverse events collected throughout the study period</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Fecal Microbiota</condition>
  <arm_group>
    <arm_group_label>Amino acid based infant formula</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Extensively hydrolyzed casein infant formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Mother's own breast milk</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Amino acid based infant formula</intervention_name>
    <arm_group_label>Amino acid based infant formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Extensively hydrolyzed casein infant formula</intervention_name>
    <arm_group_label>Extensively hydrolyzed casein infant formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mother's own breast milk</intervention_name>
    <arm_group_label>Mother's own breast milk</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Singleton, 1-7 days of age at registration or randomization

          -  Term infant with appropriate birth weight for gestational age

          -  Either solely formula fed or exclusively receiving mother's own breast milk

          -  Signed Informed Consent and Protected Health Information

        Exclusion Criteria:

          -  Caesarean delivery

          -  Infant was born from a mother with Type 1 diabetes

          -  History of underlying metabolic or chronic disease or immunocompromised

          -  Feeding difficulties or history of formula or human milk intolerance

          -  Signs of acute infection of current use of antibiotics
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>7 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jon Vanderhoof, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Mead Johnson and Company</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nancy Moore</last_name>
    <phone>812-483-1847</phone>
    <email>nancy.moore@mjn.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Midwest Children's Health Research Institue</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68504</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Layton</last_name>
      <phone>402-327-6065</phone>
    </contact>
    <investigator>
      <last_name>Brad Brabec, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 12, 2016</lastchanged_date>
  <firstreceived_date>July 15, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Caseins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
